Illumina (ILMN)

NASDAQ:ILMN

ILMN

Illumina

RESEARCH TOOLSreports

Want to see ILMN full AI Analyst Report?

Illumina (ILMN) Stock Forecast & Price Target

4,637 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ILMN Analyst Ratings

Hold

5 Buy

3 Hold

3 Sell

Based on 11 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ILMN Stock 12 Month Forecast

Average Price Target

$138.82

▲(3.21% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $138.82 with a high forecast of $170.00 and a low forecast of $95.00. The average price target represents a 3.21% change from the last price of $134.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"75":"$75","99":"$99","123":"$123","147":"$147","171":"$171"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$170.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":138.8181818181818,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$138.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$95.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[75,99,123,147,171],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,135.78,138.4123076923077,141.04461538461538,143.6769230769231,146.30923076923077,148.94153846153847,151.57384615384615,154.20615384615385,156.83846153846153,159.47076923076924,162.1030769230769,164.73538461538462,167.3676923076923,{"y":170,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,135.78,136.0137062937063,136.24741258741258,136.48111888111887,136.71482517482517,136.94853146853146,137.18223776223775,137.41594405594407,137.64965034965036,137.88335664335665,138.11706293706294,138.35076923076923,138.58447552447552,{"y":138.8181818181818,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,135.78,132.64307692307693,129.50615384615384,126.36923076923077,123.2323076923077,120.09538461538462,116.95846153846153,113.82153846153847,110.68461538461538,107.5476923076923,104.41076923076923,101.27384615384615,98.13692307692307,{"y":95,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":76.51,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.15,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.66,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.82,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.54,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":128.72,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":131.16,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":141.13,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.89,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.63,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.78,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$170.00

Average Price Target$138.82

Lowest Price Target$95.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Narumi Nakagiri

Daiwa

$155

Buy

15.24%

Upside

Upgraded

05/14/26

Illumina upgraded to Outperform from Neutral at DaiwaIllumina upgraded to Outperform from Neutral at Daiwa

Michael Ryskin

Bank of America Securities

$85→$100

Sell

-25.65%

Downside

Reiterated

05/14/26

Bank of America Securities Sticks to Its Sell Rating for Illumina (ILMN)

Patrick B Donnelly

Citi

$80→$95

Sell

-29.37%

Downside

Assigned

05/04/26

Illumina price target raised to $95 from $80 at CitiIllumina price target raised to $95 from $80 at Citi

David Westenberg

Piper Sandler

$170

Buy

26.39%

Upside

Reiterated

05/01/26

Illumina (ILMN) Receives a Buy from Piper Sandler

Vijay Kumar

Evercore ISI

$150→$155

Buy

15.24%

Upside

Reiterated

05/01/26

Illumina price target raised to $155 from $150 at Evercore ISIIllumina price target raised to $155 from $150 at Evercore ISI

Daniel Arias

Stifel Nicolaus

$155

Buy

15.24%

Upside

Reiterated

05/01/26

Stifel Nicolaus Keeps Their Buy Rating on Illumina (ILMN)

Casey Woodring

J.P. Morgan

$120→$125

Hold

-7.06%

Downside

Reiterated

05/01/26

Illumina (ILMN) Receives a Hold from J.P. Morgan

Kyle Mikson CFA

Canaccord Genuity

$150→$140

Hold

4.09%

Upside

Reiterated

05/01/26

Illumina price target lowered to $140 from $150 at CanaccordIllumina price target lowered to $140 from $150 at Canaccord

Luke Sergott

Barclays

$110→$122

Sell

-9.29%

Downside

Assigned

05/01/26

Illumina (ILMN) Receives a Sell from Barclays

Daniel Brennan

TD Cowen

$117.67→$140

Hold

4.09%

Upside

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)

Subbu Nambi

Guggenheim

$170

Buy

26.39%

Upside

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN), Axsome Therapeutics (NASDAQ: AXSM) and Kymera Therapeutics (NASDAQ: KYMR)

Dan Leonard

UBS

$120→$135

Hold

0.37%

Upside

Reiterated

02/06/26

Illumina price target raised to $135 from $120 at UBSIllumina price target raised to $135 from $120 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$132→$137

Hold

1.86%

Upside

Reiterated

02/06/26

Illumina price target raised to $137 from $132 at BairdIllumina price target raised to $137 from $132 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$108→$125

Hold

-7.06%

Downside

Reiterated

12/17/25

Jefferies Sticks to Its Hold Rating for Illumina (ILMN)

Conor McNamara

RBC Capital

$126→$124

Buy

-7.81%

Downside

Reiterated

09/02/25

Illumina (ILMN) Receives a Buy from RBC Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Narumi Nakagiri

Daiwa

$155

Buy

15.24%

Upside

Upgraded

05/14/26

Illumina upgraded to Outperform from Neutral at DaiwaIllumina upgraded to Outperform from Neutral at Daiwa

Michael Ryskin

Bank of America Securities

$85→$100

Sell

-25.65%

Downside

Reiterated

05/14/26

Bank of America Securities Sticks to Its Sell Rating for Illumina (ILMN)

Patrick B Donnelly

Citi

$80→$95

Sell

-29.37%

Downside

Assigned

05/04/26

Illumina price target raised to $95 from $80 at CitiIllumina price target raised to $95 from $80 at Citi

David Westenberg

Piper Sandler

$170

Buy

26.39%

Upside

Reiterated

05/01/26

Illumina (ILMN) Receives a Buy from Piper Sandler

Vijay Kumar

Evercore ISI

$150→$155

Buy

15.24%

Upside

Reiterated

05/01/26

Illumina price target raised to $155 from $150 at Evercore ISIIllumina price target raised to $155 from $150 at Evercore ISI

Daniel Arias

Stifel Nicolaus

$155

Buy

15.24%

Upside

Reiterated

05/01/26

Stifel Nicolaus Keeps Their Buy Rating on Illumina (ILMN)

Casey Woodring

J.P. Morgan

$120→$125

Hold

-7.06%

Downside

Reiterated

05/01/26

Illumina (ILMN) Receives a Hold from J.P. Morgan

Kyle Mikson CFA

Canaccord Genuity

$150→$140

Hold

4.09%

Upside

Reiterated

05/01/26

Illumina price target lowered to $140 from $150 at CanaccordIllumina price target lowered to $140 from $150 at Canaccord

Luke Sergott

Barclays

$110→$122

Sell

-9.29%

Downside

Assigned

05/01/26

Illumina (ILMN) Receives a Sell from Barclays

Daniel Brennan

TD Cowen

$117.67→$140

Hold

4.09%

Upside

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and Cardinal Health (NYSE: CAH)

Subbu Nambi

Guggenheim

$170

Buy

26.39%

Upside

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN), Axsome Therapeutics (NASDAQ: AXSM) and Kymera Therapeutics (NASDAQ: KYMR)

Dan Leonard

UBS

$120→$135

Hold

0.37%

Upside

Reiterated

02/06/26

Illumina price target raised to $135 from $120 at UBSIllumina price target raised to $135 from $120 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$132→$137

Hold

1.86%

Upside

Reiterated

02/06/26

Illumina price target raised to $137 from $132 at BairdIllumina price target raised to $137 from $132 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$108→$125

Hold

-7.06%

Downside

Reiterated

12/17/25

Jefferies Sticks to Its Hold Rating for Illumina (ILMN)

Conor McNamara

RBC Capital

$126→$124

Buy

-7.81%

Downside

Reiterated

09/02/25

Illumina (ILMN) Receives a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months

xxx

Success Rate

10/16 ratings generated profit

Average Return

+2.51%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +2.51% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

10/17 ratings generated profit

Average Return

+5.28%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +5.28% per trade.

2 Years

xxx

Success Rate

11/17 ratings generated profit

Average Return

+5.92%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +5.92% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILMN Analyst Recommendation Trends

Rating

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ILMN has received 5 Buy Ratings, 6 Hold Ratings, and 6 Sell Ratings. ILMN average Analyst price target in the past 3 months is 138.82.

Each month's total comprises the sum of three months' worth of ratings.

ILMN Financial Forecast

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is $1.23 with a range of $1.20 to $1.29. The previous quarter’s EPS was $1.15. ILMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is $1.13B with a range of $1.10B to $1.14B. The previous quarter’s sales results were $1.09B. ILMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 138.82.

What is ILMN’s upside potential, based on the analysts’ average price target?

Illumina has 3.21% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ILMN a Buy, Sell or Hold?

Illumina has a consensus rating of Hold which is based on 5 buy ratings, 3 hold ratings and 3 sell ratings.

What is Illumina’s price target?

The average price target for Illumina is 138.82. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $170.00 ,the lowest forecast is $95.00. The average price target represents 3.21% Increase from the current price of $134.5.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of ILMN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Illumina (ILMN) Stock Forecast & Price Target

ILMN Analyst Ratings

ILMN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

ILMN Analyst Recommendation Trends

ILMN Financial Forecast

ILMN Earnings Forecast

ILMN Sales Forecast

ILMN Stock Forecast FAQ

Detailed List of Analyst Forecasts